IL18 and urinary bladder cancer: To simulate intravesical therapy in our in vitro study, bladder cancer cell (BCC) lines were treated with RP116, IL-18/-21-pretreated expanded NK (eNK) cells, or a combination of both for 2 h, followed by washing with PBS.